Kidney Cancer
Phase I/II Study of BNC105P in Combination with Everolimus or Following Everolimus for Progressive Metastatic Clear Cell Renal Cell Carcinoma Following Prior Tyrosine Kinase Inhibitors Hoosier Oncology Group GU09-145 Synopsis: This is a Phase 2, double blind, randomized study, to be conducted in an outpatient setting. The purpose of…